Neurocrine Biosciences (NBIX) Gross Profit (2017 - 2025)
Historic Gross Profit for Neurocrine Biosciences (NBIX) over the last 8 years, with Q4 2025 value amounting to $787.9 million.
- Neurocrine Biosciences' Gross Profit rose 2740.94% to $787.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 billion, marking a year-over-year increase of 2098.39%. This contributed to the annual value of $2.8 billion for FY2025, which is 2098.39% up from last year.
- Per Neurocrine Biosciences' latest filing, its Gross Profit stood at $787.9 million for Q4 2025, which was up 2740.94% from $780.9 million recorded in Q3 2025.
- In the past 5 years, Neurocrine Biosciences' Gross Profit ranged from a high of $787.9 million in Q4 2025 and a low of $233.7 million during Q1 2021
- In the last 4 years, Neurocrine Biosciences' Gross Profit had a median value of $507.8 million in 2024 and averaged $519.2 million.
- In the last 5 years, Neurocrine Biosciences' Gross Profit crashed by 473.33% in 2021 and then skyrocketed by 3168.63% in 2024.
- Over the past 4 years, Neurocrine Biosciences' Gross Profit (Quarter) stood at $291.8 million in 2021, then soared by 73.65% to $506.7 million in 2023, then increased by 22.04% to $618.4 million in 2024, then grew by 27.41% to $787.9 million in 2025.
- Its last three reported values are $787.9 million in Q4 2025, $780.9 million for Q3 2025, and $676.2 million during Q2 2025.